The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atracurium besilate 10 mg/ml solution for injection/infusion

10 milligram(s)/millilitre Solution for injection/infusion

AS KALCEKSPA2165/001/001

Main Information

Trade NameAtracurium besilate 10 mg/ml solution for injection/infusion
Active SubstancesAtracurium besilate
Strength10 milligram(s)/millilitre
Dosage FormSolution for injection/infusion
Licence HolderAS KALCEKS
Licence NumberPA2165/001/001

Group Information

ATC CodeM03AC Other quaternary ammonium compounds
M03AC04 atracurium

Status

Authorised/WithdrawnAuthorised
Licence Issued24/11/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back